Drug Trial Radar · NCT05467748
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Dec 8, 2025
Primary completion
Dec 8, 2027
Study completion Dec 7, 2029
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- Collaborators
- VA Greater Los Angeles Healthcare System
- First posted
- Jul 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, single arm, phase Ib/II clinical trial of checkpoint blockade, pembrolizumab and EZH2 inhibitor, tulmimetostat combination therapy for patients with advanced non-small cell lung cancer who have progressed from front or second-line treatment. Patients will be enrolled at multiple Veterans Affairs Medical Centers.
Conditions
- Non Small Cell Lung Cancer
Interventions
TulmimetostatDrug
combination of oral tazemetostat and intravenous pembrolizumab treatment for patients with advanced non-small cell lung cancer
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: 2 years
- Safety and TolerabilityTime frame: 2 years
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California · Not yet recruiting
VA Northern California Health Care System, Mather, CA
Sacramento, California · Not yet recruiting
VA San Diego Healthcare System, San Diego, CA
San Diego, California · Recruiting
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan · Recruiting
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.